Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mitral Valve Prolapse I: Introduction01:27

Mitral Valve Prolapse I: Introduction

IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

PCI for Ostial Stenosis of Left Circumflex or Left Anterior Descending Artery.

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions·2026
Same author

Early repolarization pattern in patients with malignant coronary artery anomalies.

Journal of electrocardiology·2026
Same author

Crossover Versus Ostial Single-stent Implantation for Ostial Left Circumflex Artery Lesions: the Multicenter CROSS-LCX Registry.

The Canadian journal of cardiology·2026
Same author

Management of coexisting myocardial bridging and hypertrophic cardiomyopathy.

La Clinica terapeutica·2026
Same author

Optimizing High-Risk Left Main PCI With Current Evidence.

Coronary artery disease·2026
Same author

Management of Transcatheter Pulmonary Valve Thrombosis With Low-Dose, Slow-Infusion Fibrinolytic Therapy.

JACC. Case reports·2026

Related Experiment Video

Updated: May 16, 2026

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair
08:31

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair

Published on: October 16, 2021

Relationship between mean platelet volume and mitral annular calcification.

Ercan Varol1, Fatih Aksoy, Mehmet Ozaydin

  • 1Department of Cardiology, Suleyman Demirel University, Isparta, Turkey. drercanvarol@yahoo.com

Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis
|November 22, 2012
PubMed
Summary

Mitral annular calcification (MAC) is linked to increased platelet activation, indicated by higher mean platelet volume (MPV) and platelet distribution width (PDW). These markers are independently associated with MAC, suggesting a role in cardiovascular disease risk.

More Related Videos

Identifying Coronary Artery Calcification on Non-gated Computed Tomography Scans
04:40

Identifying Coronary Artery Calcification on Non-gated Computed Tomography Scans

Published on: August 28, 2018

Novel Quantification Protocol for Cardiovascular Calcification Progression Using Longitudinal MicroPET/MicroCT Images
08:02

Novel Quantification Protocol for Cardiovascular Calcification Progression Using Longitudinal MicroPET/MicroCT Images

Published on: November 15, 2024

Related Experiment Videos

Last Updated: May 16, 2026

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair
08:31

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair

Published on: October 16, 2021

Identifying Coronary Artery Calcification on Non-gated Computed Tomography Scans
04:40

Identifying Coronary Artery Calcification on Non-gated Computed Tomography Scans

Published on: August 28, 2018

Novel Quantification Protocol for Cardiovascular Calcification Progression Using Longitudinal MicroPET/MicroCT Images
08:02

Novel Quantification Protocol for Cardiovascular Calcification Progression Using Longitudinal MicroPET/MicroCT Images

Published on: November 15, 2024

Area of Science:

  • Cardiovascular Medicine
  • Hematology
  • Biomarkers

Background:

  • Mitral annular calcification (MAC) is a significant cardiovascular disease risk factor, sharing common risk factors with atherosclerosis.
  • MAC is associated with increased risks of coronary artery disease, heart failure, and stroke.
  • Platelet activation plays a crucial role in atherothrombosis and cardiovascular events.

Purpose of the Study:

  • To investigate the association between mean platelet volume (MPV), a marker of platelet activation, and mitral annular calcification (MAC).
  • To compare MPV and other platelet indices in patients with MAC versus a control group.
  • To determine if MPV and platelet distribution width (PDW) are independent predictors of MAC.

Main Methods:

  • A case-control study involving 101 patients with MAC and 55 age, sex, and BMI-matched controls without MAC.
  • Measurement of platelet indices, including MPV and PDW, in all study participants.
  • Statistical analysis to compare platelet indices between groups and assess correlations and independent associations with MAC.

Main Results:

  • Patients with MAC exhibited significantly higher MPV (8.9 ± 0.8 fl vs. 8.0 ± 0.9 fl) and PDW (15.8 ± 1.3% vs. 15.0 ± 1.3%) compared to controls (P < 0.001 for both).
  • MPV showed a positive correlation with MAC severity (r=0.47, P<0.001), atrial fibrillation, and left atrial size, and a negative correlation with platelet count.
  • Both MPV (OR 3.89) and PDW (OR 2.27) were independently associated with MAC, indicating their predictive value.

Conclusions:

  • Mean platelet volume (MPV) and platelet distribution width (PDW) are significantly elevated in patients with mitral annular calcification (MAC).
  • Elevated MPV and PDW are independently associated with MAC, suggesting their potential as biomarkers for cardiovascular risk.
  • These findings highlight the role of platelet activation in the pathophysiology of MAC and related cardiovascular disorders.